Availability and effectiveness of decision aids for supporting shared decision making in patients with advanced colorectal and lung cancer: Results from a systematic review

Inge Spronk, Maartje C. Meijers, Marianne J. Heins, Anneke L. Francke, Glyn Elwyn, Anne van Lindert, Sandra van Dulmen, Liesbeth M. van Vliet

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Introduction: Shared decision making is not always commonplace in advanced colorectal or lung cancer care. Decision aids (DAs) might be helpful. This review aimed (a) to provide an overview of DAs for patients with advanced colorectal or lung cancer and assess their availability; and (b) to assess their effectiveness if possible. Methods: A systematic literature search (PubMed/EMBASE/PsycINFO/CINAHL) and Internet and expert searches were carried out to identify relevant DAs. Data from the DAs included were extracted and the quality of studies, evidence (Grading of Recommendations Assessment, Development and Evaluation) and effectiveness (International Patient Decision Aid Standards) of DAs were determined. Results: Ten of the 12 DAs included (four colorectal cancer, four lung cancer and four generic) are still available. Most (9/12) were applicable throughout the disease pathway and usable for all decisions, or to the decision for supportive care with/without anti-cancer therapy. Seven studies tested effectiveness. Effects on patient outcomes varied, but were generally weakly positive (e.g., DAs improved patient satisfaction) with low evidence. Study quality was fair to good. Conclusion: There is a lack of readily available DAs that have been demonstrated to be effective in advanced colorectal or lung cancer. Rigorous testing of the effects of currently available and future DAs, to improve patient outcomes, is urgently needed.
Original languageEnglish
Article numbere13079
JournalEuropean Journal of Cancer Care
Volume28
Issue number3
DOIs
Publication statusPublished - 2019

Cite this

Spronk, Inge ; Meijers, Maartje C. ; Heins, Marianne J. ; Francke, Anneke L. ; Elwyn, Glyn ; van Lindert, Anne ; van Dulmen, Sandra ; van Vliet, Liesbeth M. / Availability and effectiveness of decision aids for supporting shared decision making in patients with advanced colorectal and lung cancer: Results from a systematic review. In: European Journal of Cancer Care. 2019 ; Vol. 28, No. 3.
@article{bc6b21544edc4f2f8d9b0444243e1e8f,
title = "Availability and effectiveness of decision aids for supporting shared decision making in patients with advanced colorectal and lung cancer: Results from a systematic review",
abstract = "Introduction: Shared decision making is not always commonplace in advanced colorectal or lung cancer care. Decision aids (DAs) might be helpful. This review aimed (a) to provide an overview of DAs for patients with advanced colorectal or lung cancer and assess their availability; and (b) to assess their effectiveness if possible. Methods: A systematic literature search (PubMed/EMBASE/PsycINFO/CINAHL) and Internet and expert searches were carried out to identify relevant DAs. Data from the DAs included were extracted and the quality of studies, evidence (Grading of Recommendations Assessment, Development and Evaluation) and effectiveness (International Patient Decision Aid Standards) of DAs were determined. Results: Ten of the 12 DAs included (four colorectal cancer, four lung cancer and four generic) are still available. Most (9/12) were applicable throughout the disease pathway and usable for all decisions, or to the decision for supportive care with/without anti-cancer therapy. Seven studies tested effectiveness. Effects on patient outcomes varied, but were generally weakly positive (e.g., DAs improved patient satisfaction) with low evidence. Study quality was fair to good. Conclusion: There is a lack of readily available DAs that have been demonstrated to be effective in advanced colorectal or lung cancer. Rigorous testing of the effects of currently available and future DAs, to improve patient outcomes, is urgently needed.",
author = "Inge Spronk and Meijers, {Maartje C.} and Heins, {Marianne J.} and Francke, {Anneke L.} and Glyn Elwyn and {van Lindert}, Anne and {van Dulmen}, Sandra and {van Vliet}, {Liesbeth M.}",
year = "2019",
doi = "10.1111/ecc.13079",
language = "English",
volume = "28",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",
number = "3",

}

Availability and effectiveness of decision aids for supporting shared decision making in patients with advanced colorectal and lung cancer: Results from a systematic review. / Spronk, Inge; Meijers, Maartje C.; Heins, Marianne J.; Francke, Anneke L.; Elwyn, Glyn; van Lindert, Anne; van Dulmen, Sandra; van Vliet, Liesbeth M.

In: European Journal of Cancer Care, Vol. 28, No. 3, e13079, 2019.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Availability and effectiveness of decision aids for supporting shared decision making in patients with advanced colorectal and lung cancer: Results from a systematic review

AU - Spronk, Inge

AU - Meijers, Maartje C.

AU - Heins, Marianne J.

AU - Francke, Anneke L.

AU - Elwyn, Glyn

AU - van Lindert, Anne

AU - van Dulmen, Sandra

AU - van Vliet, Liesbeth M.

PY - 2019

Y1 - 2019

N2 - Introduction: Shared decision making is not always commonplace in advanced colorectal or lung cancer care. Decision aids (DAs) might be helpful. This review aimed (a) to provide an overview of DAs for patients with advanced colorectal or lung cancer and assess their availability; and (b) to assess their effectiveness if possible. Methods: A systematic literature search (PubMed/EMBASE/PsycINFO/CINAHL) and Internet and expert searches were carried out to identify relevant DAs. Data from the DAs included were extracted and the quality of studies, evidence (Grading of Recommendations Assessment, Development and Evaluation) and effectiveness (International Patient Decision Aid Standards) of DAs were determined. Results: Ten of the 12 DAs included (four colorectal cancer, four lung cancer and four generic) are still available. Most (9/12) were applicable throughout the disease pathway and usable for all decisions, or to the decision for supportive care with/without anti-cancer therapy. Seven studies tested effectiveness. Effects on patient outcomes varied, but were generally weakly positive (e.g., DAs improved patient satisfaction) with low evidence. Study quality was fair to good. Conclusion: There is a lack of readily available DAs that have been demonstrated to be effective in advanced colorectal or lung cancer. Rigorous testing of the effects of currently available and future DAs, to improve patient outcomes, is urgently needed.

AB - Introduction: Shared decision making is not always commonplace in advanced colorectal or lung cancer care. Decision aids (DAs) might be helpful. This review aimed (a) to provide an overview of DAs for patients with advanced colorectal or lung cancer and assess their availability; and (b) to assess their effectiveness if possible. Methods: A systematic literature search (PubMed/EMBASE/PsycINFO/CINAHL) and Internet and expert searches were carried out to identify relevant DAs. Data from the DAs included were extracted and the quality of studies, evidence (Grading of Recommendations Assessment, Development and Evaluation) and effectiveness (International Patient Decision Aid Standards) of DAs were determined. Results: Ten of the 12 DAs included (four colorectal cancer, four lung cancer and four generic) are still available. Most (9/12) were applicable throughout the disease pathway and usable for all decisions, or to the decision for supportive care with/without anti-cancer therapy. Seven studies tested effectiveness. Effects on patient outcomes varied, but were generally weakly positive (e.g., DAs improved patient satisfaction) with low evidence. Study quality was fair to good. Conclusion: There is a lack of readily available DAs that have been demonstrated to be effective in advanced colorectal or lung cancer. Rigorous testing of the effects of currently available and future DAs, to improve patient outcomes, is urgently needed.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065993081&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31066142

U2 - 10.1111/ecc.13079

DO - 10.1111/ecc.13079

M3 - Review article

VL - 28

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

IS - 3

M1 - e13079

ER -